Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allo-ASC for Intractable Common Extensor Tendon Injury
NCT03449082Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2018
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in Lateral Epicondylitis (LET), sponsored by Seoul National University Hospital. Started Mar 2018; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT03449082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449082.